Status:
COMPLETED
Effect of Catheter Ablation on Left Atrial Function in Persistent Atrial Fibrillation
Lead Sponsor:
The Second Hospital of Hebei Medical University
Conditions:
Persistent Atrial Fibrillation
Eligibility:
All Genders
Up to 80 years
Phase:
NA
Brief Summary
A total of 106 patients with drug-refractory persistent atrial fibrillation, who are planned to undergo circumferential pulmonary vein isolation (CPVI), will be randomly allocated into two groups. The...
Detailed Description
From February 2018 to February 2020, the investigators enroll consecutive patients with drug-refractory persistent atrial fibrillation who were scheduled for an initial catheter ablation.Patients are ...
Eligibility Criteria
Inclusion
- Persistent
- Persistent AF is defined as AF that persists without interruption for 7 days (electrocardiogram data or Holter), atrial fibrillation cannot be prevented in patients who orally take class I and III antiarrhythmic drugs, and patient age is \<80 years.
Exclusion
- •left ventricular dysfunction
- atrial thrombosis
- valvular heart disease
- hyperthyroidism
- patients who underwent prosthetic heart valve replacement
- patients with previous history of atrial fibrillation ablation
- pregnant women
- patients with existing liver and kidney disease
- malignant tumors
- hematological system diseases
Key Trial Info
Start Date :
February 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2020
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT03443232
Start Date
February 16 2018
End Date
March 17 2020
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China, 050000